Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HTR1B | P28222 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302714 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL303905 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL304715 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL302934 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL304218 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL303925 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL303704 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL303784 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL302668 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 | |
| SCHEMBL303607 | 0.98 | CHAT (0.52) | CHATCNR1GAAKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | claimed |
| WO-2023125184-A1 | TERTIARY AMINE LIPID COMPOUND AND USE THEREOF | 华南理工大学 | 2023-07-06 | — | — | WO | claimed |
| CN-1738829-B | New 2',5'-oligoadenylic acid analog | SANKYO CO | 2012-11-28 | — | — | CN | claimed |
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-07-18 | — | — | US | disclosed |
| EP-4234609-B1 | METHODS FOR PURIFICATION, DETECTION AND QUANTIFICATION OF RESIDUAL PEI-BASED TRANSFECTION REAGENTS | POLYPLUS TRANSFECTION (FR) | 2024-07-17 | — | — | EP | disclosed |
| EP-4375280-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-29 | — | — | EP | disclosed |
| EP-4371985-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-22 | — | — | EP | disclosed |
| EP-4371984-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-22 | — | — | EP | disclosed |
| EP-4019607-B1 | ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INT (FR) | 2024-05-15 | — | — | EP | disclosed |
| CN-117881673-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-12 | — | — | CN | disclosed |
| CN-117836290-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-05 | — | — | CN | disclosed |
| EP-0501656-A2 | New benzene derivatives having (NGF) production-promoting activity | Sankyo Company Limited (JP) | 1992-09-02 | — | — | EP | disclosed |
| EP-0498680-A1 | New beta-amino-alpha-hydroxycarboxylic acids and their use | Sankyo Company Limited (JP) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991014719-A2 | IMPROVED POLYBUTENE PROCESS | EXXON CHEMICAL PATENTS INC. (US) | 1991-10-03 | — | — | WO | disclosed |
| US-4952739-A | ORGANOALUMINUM AND HYDROGEN CHLORIDE POLYMERIZATION CATALYST | EXXON CHEMICAL PATENTS INC. (US) | 1990-08-28 | — | — | US | disclosed |
| US-4935576-A | Polybutene process | EXXON CHEMICAL PATENTS INC. (US) | 1990-06-19 | — | — | US | disclosed |
| EP-0370805-A2 | Improved polybutene process | EXXON CHEMICAL PATENTS INC. (US) | 1990-05-30 | — | — | EP | disclosed |
| EP-0367385-A2 | Improved organo-A1-chloride catalyzed poly-n-butenes process | EXXON CHEMICAL PATENTS INC. (US) | 1990-05-09 | — | — | EP | disclosed |
| US-4427640-A | Sequential process for extraction and recovery of vanadium and uranium from wet process acids | KERR-MCGEE CHEMICAL CORPORATION (US) | 1984-01-24 | — | — | US | disclosed |
| US-4329350-A | VASODILATORS | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | CYP7A1, UGT1A3, UGT1A1 | CHAT 1906/4885CNR1 3189/4885GAA 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.